Work

FRI-245 Longitudinal follow-up of Fib-4 in patients at risk of steatotic liver disease (SLD) receiving low-dose Methotrexate treatment (LDMTX): results from the CIRT randomized placebo-controlled Trial in 4769 patients

Year: 2024

Type: conference-abstract

Source: Journal of Hepatology

DOI: 10.1016/s0168-8278(24)01474-0

Authors: Vincent Di Martino, Jing Cui, Delphine Weil-Verhoeven, Daniel Solomon

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399560432

Cites:

Cited by:

Related to: 10